Clinical trial
Effect of Antiviral Therapy on HVPG in Patients With Viral Cirrhosis
NCT04797910 is registered in ClinicalTrials.gov with Nanfang Hospital, Southern Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Antiviral Therapy on HVPG in Patients With Viral Cirrhosis
- Lead sponsor
- Nanfang Hospital, Southern Medical University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- March 10, 2021
- Completion date
- December 31, 2022
- Enrollment
- 24 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
portal hypertension